May 2-3, 2017: San Diego, CA

Agenda

Fortune Brainstorm HEALTH offers a dynamic mix of one-on-one interviews, panel discussions, interactive roundtables and far-ranging Q&As.

Brainstorm HEALTH 2017 will bring the signature Fortune Brainstorm interactive format to generate new ideas and fresh thinking, while encouraging a hand-selected group of thought-leaders to work jointly on problem solving. Participants will tackle the big questions of how technology can reshape all aspects of health, including personal wellness, intervention, cost efficiency, and research. Fortune’s goal is to gather together those on the front lines of the industry, provide a forum for them to share their cutting-edge ideas on how businesses can lead in this field, and then disseminate these ideas in the magazine and beyond.

Tuesday, May 2, 2017

11:00 AM REGISTRATION OPENS

11:45 AM OPTIONAL LUNCH: WORKPLACE WELLNESS INNOVATION

Hosted by Cigna

Americans spend more than half of their waking hours at work—often seat-strapped, deskbound, or flat on their feet for much of that time. Gym breaks are a luxury for a few; eating on the run, a reality for many. Such stasis, say experts—and, well, everyone else, too—isn’t exactly a recipe for human fitness, sharp minds, or bristling productivity. Enter workplace wellness programs—a fix that would seem, on first glance, to be too obvious to ignore. A majority of companies, indeed, now offer some sort of wellness benefits—spending as much as $8 billion on everything from flu shots and health screenings to gym memberships, personal health coaching and weight loss programs. But here’s a dumb question: Is this money being well spent? In this candid conversation, we’ll probe whether today’s wellness programs really are bringing wellness to employees, how they’re impacting productivity and the bottom line, and how to measure their success and keep employees engaged beyond week one.

Chip Bergh, President and CEO, Levi Strauss & Co.
Dr. Nicholas J. Gettas, Chief Medical Officer, Regional, Government, Select, and Individual & Family Plans; National Medical Officer, Market-facing Clinical Organization, Cigna
Amy McDonough, Vice President and General Manager, Fitbit Group Health
Rick Valencia, President, Qualcomm Life
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm HEALTH

2:00 PM WELCOME

Alan Murray, President, Fortune, and Chief Content Officer, Time Inc.

2:05 PM SETTING THE AGENDA: THE REVOLUTION IS NOW

We launched Brainstorm HEALTH in November 2016 to explore the crossroads of health care, technology and innovation—only to discover how jammed this intersection is with passionate entrepreneurs, visionary thinkers and bold ideas. No surprise, we couldn’t wait a full year to come back for more. So once again, we’ve gathered the most ambitious minds in medicine, science, and disruptive technology to probe this realm—and this time, we’re focusing our collective lens on the here and now. How can we improve lives, reduce costs, and spread the benefits of health tech today? How do we get investment into the right areas quickly? If AI, VR, 3-D are truly transformative technologies, how long until we witness their impact—and where will the first breakthroughs happen? Over the next day and a half, we’ll take a collective dive into the actual miracles of the age. We’ll see what’s working and what isn’t—and we’ll tackle the question that lies at the heart of this revolution: What do we need to do now to make healthcare healthy enough for the 21st century
Dr. David B. Agus, Co-chair, Fortune Brainstorm HEALTH; Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, USC
Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm HEALTH

2:15 PM MOVING FAST AMID THE FLUX

With Republican efforts to “repeal and replace” Obamacare in legislative limbo, and with potentially enormous changes in federal budget outlays on the horizon, the outlook for healthcare policy is cloudier than it has been in years—adding yet another challenge to those who want to invest and innovate in this area. But the simple fact is, a trillion-dollar industry can’t (and won’t) wait to act until all the answers are in hand. Neither start-up explorers nor big companies that hope to take the lead can afford to sit still. And they don’t have to. Here’s how to move forward—even before we know whether Obamacare or Trumpcare will be the law of the land.
Dr. David B. Agus, USC
Dr. Steven J. Corwin, President and CEO, NewYork-Presbyterian
Moderator: Alan Murray, Time Inc.

2:45 PM IN SEARCH OF PRECISION HEALTH

There is still heated debate over whether “precision medicine” is a realizable goal or merely an empty promise. But is it even the goal we should be aiming for? A more worthy destination, say some, is precision health—harnessing science and technology for individualized disease prevention and wellness. The approach isn’t just about finding our “broken” parts and repairing them with molecularly targeted drugs. It’s about seeing the whole. Getting personal in healthcare, it seems, will require a pretty global worldview of the human body.
Dr. Shelley Hwang, Chief of Breast Surgery and Professor and Vice Chair of Research, Department of Surgery, Duke University
Dr. Lloyd B. Minor, Carl and Elizabeth Naumann Dean, School of Medicine, Stanford University
Moderator: Clifton Leaf, Fortune

3:05 PM DEMO: HIJACKING THE BRAIN WITH VR

Virtual reality is emerging as a powerful tool to address some of society’s most pressing mental health issues. Here’s a thought-provoking—and death-defying—peek at how VR can override our logical mind, help us overcome our fears, and potentially transform treatment for everything from PTSD to depression and addiction.
Matthew Stoudt, Co-founder and CEO, appliedVR

3:15 PM THE EVOLUTION OF EATING

Consumers are fleeing these days from anything that has ingredients that are too hard to pronounce—and this quest for food simplicity has given rise to a host of startups that are eating into the sales of traditional packaged food giants. Can the old guard transform itself—and help change the way we eat in the decade to come? (And worth asking: Are these new offerings better for us to begin with?) A provocative conversation with two leaders of the Big Food pack.
Tom Hayes, President and CEO, Tyson Foods, Inc.
Denise Morrison, President and CEO, Campbell Soup Co.
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune

3:40 PM BREAK

4:05 PM THE GOOD, THE BAD, AND THE SCARY: WHERE GENOMIC TECH MAY LEAD

What happens when the same technology that can edit out a disease-causing mutation can edit the genetic code of a virus to make it more pathogenic? What happens when we replace the four building blocks of DNA with six—that is to say, the four nucleic acids that have stood through billions of years of evolution plus two new versions that came out of a San Diego lab last year? Sometimes, progress isn’t just messy, it’s scary. Here, a conversation about the brave new world of gene-tech—and why we neither can nor should put the genie back in the bottle.
Othman Laraki, Co-founder and CEO, Color Genomics
Dr. Eric J. Topol, Founder and Director, Scripps Translational Science Institute
Dr. J. Craig Venter, Co-Founder, Executive Chairman, and Head of Scientific Strategy, Human Longevity, Inc.

Moderator: Siobhan O’Connor, Co-chair, Fortune Brainstorm HEALTH; Journalist and Executive Editor, Time Magazine

4:30 PM DEMO: CAN YOU STOP YOUR OWN BRAIN-DRAIN?

Nearly all of us overestimate our ability to multitask—and here’s a quick proof.

4:35 PM WHY YOUR BRAIN WASN’T MEANT TO MULTITASK

Put down your smartphone and focus: turns out all that multitasking is actually harming, not helping, your productivity. A critical look at why we are overestimating our ability to multitask, something our brains aren’t built for. Learn how to set digital boundaries, how to practice the art of attention and why responding immediately to texts and e-mail is not necessarily a good thing.
Dr. Adam Gazzaley, Professor in Neurology, Physiology and Psychiatry, UC San Francisco; Founder and Executive Director, Neuroscape
Interviewer: Clifton Leaf, Fortune

4:45 PM MEET THE VC BEHIND SOME OF BIOTECH’S BIGGEST HITS

In 2016, there were a record number of deals in health-tech companies—but will the momentum continue? What startups and later-stage ventures are leading the charge? What are the big themes and knockdown challenges for healthcare investors today? We sit down with one of the sector’s most prolific and successful philosopher-investors: Venrock’s Bryan Roberts.
Dr. Bryan Roberts, Partner, Venrock

5:05 PM DEMO: THE IMPLANTABLE DRUG THAT COULD ONE DAY PREVENT HIV

An up-close look at a new way of taking medicine: a matchstick-size device that when implanted under the skin releases a steady, continuous, and low-dose stream of medicine. Intarcia Therapeutics Inc. is now focused on delivering a drug for diabetes, but the possibilities don’t end there. Could this approach be used to stave off HIV, malaria and other infections?
Kurt Graves, Chairman, President, and CEO, Intarcia

5:10 PM WAGING THE WAR ON AIDS: A BATTLE HIGH-TECH AND LOW

Though gone from daily headlines in the U.S., the war against HIV/AIDS rages on. The good news: In much of the U.S. and some parts of Africa, infection rates have finally slowed thanks to expanded prevention methods and breakthrough drugs. But much work still needs to be done in hotspots around the country—and the globe. We talk with two pioneering physicians—one of whom is overseeing the world’s largest HIV vaccine trial and the other led a groundbreaking successful pilot in the U.S.—to see how far we are from getting to zero.
Dr. Larry Corey, Principal Investigator, HIV Vaccine Trials Network; Past President and Director,
Fred Hutchinson Cancer Research Center
Dr. Diane Havlir, Professor of Medicine, University of California, San Francisco
Moderator: Siobhan O’Connor, Time Magazine

5:30 PM NEW ROLE MODELS: WHY HEALTH AT THE TOP IS GOOD FOR THE BOTTOM LINE

Arianna Huffington, Founder and CEO of Thrive Global, interviews two of her own role models when it comes to wellness and the workplace. Hear from a pair of leaders who have put employee well being first—and whose companies are now reaping the benefits.
Chip Bergh, President and CEO, Levi Strauss & Co.
Deborah DiSanzo, General Manager, IBM Watson Health
Barry Sommers, Chief Executive Officer, Wealth Management, J.P. Morgan Chase & Co.
Moderator: Arianna Huffington, Founder and CEO, Thrive Global

6:00 PM RECEPTION

7:30 PM DINNER AND FEATURED INTERVIEW

Hosted by IBM Watson Health

WELCOME
Deborah DiSanzo, General Manager, IBM Watson Health

THE URGENCY OF NOW: VICE PRESIDENT JOE BIDEN AND THE FIGHT AGAINST CANCER — A KEYNOTE CONVERSATION
Under Vice President Biden’s leadership, the White House Cancer Moonshot Task Force catalyzed novel, innovative and impactful collaborations among twenty government agencies, departments and White House offices and over seventy private sector entities designed to achieve a decade’s worth of progress in five years in the prevention, diagnosis and treatment of cancer. He helped lead the effort to pass the 21st Century Cures Act that provides an additional $1.8 billion investment over seven years for the Cancer Moonshot’s scientific priorities.

Now, after more than 40 years of public service, Vice President Biden has recommitted himself to inject a sense of urgency into our cancer research enterprise and to reimagine how the government, academia, non-profits and the private sector can better organize their resources and systems to collaborate to take on cancer. In a 1-on-1 interview, Vice President Biden sits down with Dr. David Agus to talk about the progress made through the Cancer Moonshot and the strategy for the work ahead, including how we must change the culture in the fight to end cancer.
Joseph R. Biden Jr., 47th Vice President, United States
Interviewer: Dr. David B. Agus, USC

9:00 PM CLOSE

Wednesday, May 3, 2017

7:00 AM REGISTRATION OPENS

7:45 AM CONCURRENT BREAKFAST SOLUTION SESSIONS

Attendees will choose one of three breakout sessions.

THE SCIENCE OF SLEEP
Personal Wellness Track Hosted by Cigna
Manchester Room
The word “cure” may be a hair too far, but scientists are discovering that far from being a luxury, sleep may be the antidote to many modern medical ills. There’s also mounting evidence that not only does sleep deprivation lead to life-shortening stress and disease, but that sleep itself might be restorative and even life-extending. Just last year, insufficient sleep was added to a list of major risk factors that hasten death by any cause. That’s because sleep’s essential biological purpose—which has long flummoxed researchers—is now better understood than ever. So why do so few of us still get enough of it? What happens if we don’t? And how can companies, school boards and public health officials reframe sleep as critical to good health?
Mary Carskadon, Professor, Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University; Adjunct Professor, University of South Australia
Conor Heneghan, Director of Research, Fitbit
Dr. Matthew P. Walker, Professor of Psychology and Neuroscience; Director, Sleep and Neuroimaging Laboratory, UC Berkeley
Dr. Jamie Zeitzer, Assistant Professor of Psychiatry and Behavioral Sciences, Stanford University
Moderator: Siobhan O’Connor, Time Magazine

HEALTHCARE FOR 100 MILLION CHILDREN
Intervention Track
Ballroom C1
Advances in science and technology are pushing medicine ever forward and saving countless lives. But far simpler care can save tens of millions more each year—if we can get it to where it’s needed most. Indeed, around the world, 400 million people— a large percentage of them children— still lack access to the most basic of health services. We’ll explore ways to get urgently-needed care to the next generation, including by training and deploying at scale community health workers who can help stave off persistent threats such as malnutrition and vaccine-preventable diseases.
Maria Cavalcanti, President and CEO, Pro Mujer
Jackie Chang, Head of Mobile Inclusion Partnerships, Facebook
Dr. Gary Gottlieb, Chief Executive Officer, Partners In Health
Dr. Stuart Lustig, Medical Director, Behavioral Health, Cigna
Dr. Raj Panjabi, Chief Executive Officer, Last Mile Health
Prem Ramaswami, Senior Product Manager, Google Inc.
Jeffrey C. Walker, Vice Chair, United Nations Secretary General’s Envoy for Health
Moderator: Clifton Leaf, Fortune

A NEW PLAYBOOK FOR HEALTHCARE INVESTING
Value Chain Track
Capella Room
Start with what we do know: There is a flotilla of new technologies out there on the high seas of health innovation and only some of it will make its way to shore. Now throw in what we don’t know—as in, what exactly lies beyond Obamacare? And it’s a wonder that any investor feels confident enough to bet a dollar in this ever-changing domain. But bet they did—pouring $4.2 billion into digital health companies in 2016 alone. So where’s the smart money in health care headed now? And where should health and tech companies themselves place their next big wagers? A roundtable discussion.
Vishal Amin, Partner, Andreessen Horowitz
Christine Aylward, Strategic Adviser and Investor
Ted Maidenberg, Co-founder and Partner, Social Capital
Michael Polansky, Chief Executive Officer, Parker Group
Dr. John Schilling, Partner, TPG Capital
Moderator: Adam Lashinsky, Executive Editor and Editorial Director, Brainstorm TECH, Fortune

8:45 AM SWITCH BREAK

9:05 AM A CEO’S JOURNEY: FROM SELF-DISCOVERY TO DISRUPTION

Mark Bertolini is one of the most forceful advocates calling for a change in corporate culture—one where the company’s focus isn’t just on the bottom line, but also on the wellness of its employees. The fact that he’s also the CEO of the country’s largest health insurer makes the message all the more compelling. In a freewheeling 1-on-1 interview with Time Inc.’s Chief Content Officer, Alan Murray, Bertolini relates how two very personal health care crises dramatically transformed his management philosophy—and why other corporate leaders should take heed.
Mark T. Bertolini, Chairman and CEO, Aetna Inc.
Interviewer: Alan Murray, Time Inc.

9:30 AM THE THREE-PARENT BABY

In vitro fertilization using DNA from three parents is now officially sanctioned in the U.K. The controversial method can prevent horrific genetic diseases from being passed on to children. But the advent of such revolutionary technologies, as well as others such as CRISPR-Cas9 and gene-editing, have raised concerns about a brave new world where “designer babies” are a possibility. Do those worries line up with the actual science? And what is the best way to address the legitimate ethical concerns surrounding such methods? Meet the doctor who helped pioneer the technique for the world’s first three-person baby.
Dr. John Zhang, Founder and Director, New Hope Fertility Clinic
Interviewer: Dr. David B. Agus, USC

9:45 AM THE CONSUMER’S CODE: SHARING THE GENOME’S SECRETS

One woman founded one of India’s fastest-growing life science companies and now heads a big global brand in genomics. The other, a former White House aide to President Obama, tested positive for the BRCA2 gene mutation that has led to breast cancer in her family for generations—and is taking aggressive steps to avoid the same fate. Today, we all sit at the base of the genomic Tree of Knowledge, facing questions—sometimes urgent ones—of ethics, health, science, and personal choice. The first question: Can we afford this knowledge? And the second: Can we afford to live without it?
Anu Acharya, Chief Executive Officer, Mapmygenome India Ltd.
Alejandra Campoverdi, Women’s Health Advocate
Moderator: Adam Lashinsky, Fortune

10:05 AM DEMO: CONNECTING HEART EXAMS TO THE CLOUD

Millions of patients in India die every year from heart attacks because they do not receive an immediate diagnosis or treatment. We will take you live to an Indian health clinic — and see how electrocardiograms connected to the cloud have the potential to save millions of lives. How far can this technology go toward improving healthcare outcomes for the world’s developing economies?
Vikram Damodaran, Chief Product Officer, Sustainable Health Solutions, GE Healthcare
Charit Bhograj, Chief Executive Officer, Tricog Health

10:15 AM CAN THE RIGHT DATA KILL CANCER?

Groupon co-founder and serial entrepreneur Eric Lefkofsky is embarking on his biggest challenge yet: taking on cancer. His newest venture, Tempus, aims to create one of the largest genomic databases of clinical cancer data so that patients can truly personalize their treatments. Many others before him, of course, have followed a similar path in search of a cancer breakthrough, and failed. So why is Lefkofsky so confident? The entrepreneur shares his secret.
Eric Lefkofsky, Co-Founder and CEO, Tempus
Interviewer: Dr. David B. Agus, USC

10:35 AM BREAK

11:05 AM DEMYSTIFYING AI

It has the power, in theory, to squeeze the lifetime learning of the world’s best oncologists into a single, split-second diagnosis. It has the capacity to read any X-ray image with the studied knowledge of a continent’s worth of radiologists—or to take the lessons learned from a billion trial-and-error investigations and apply them to solving any mystery. Powerful deep learning algorithms and cognitive computing systems are real at last—and they’re transforming healthcare by the day. Or are they? A frank discussion on the hype, the hope…and the actually happening…of AI.
Robert Merkel, General Manager, Oncology and Genomics, IBM Watson Health
Gene Saragnese, Chairman and CEO, MedyMatch
Dr. Morten Sogaard, Vice President & Global Head, WRD Genome Sciences & Technologies, Pfizer
Moderator: Clifton Leaf, Fortune

11:35 AM BEYOND EBOLA

The Ebola outbreak that began in West Africa in 2014 killed more than 11,000 people in six countries and took over two years to contain. So what did the global community learn from its response to the deadly virus—and how can we use this knowledge to help us avoid mistakes when the next global health crisis arises? Here, a candid conversation with two extraordinary physicians who fought the battle, and saw its ravages, on the frontline.
Dr. Nahid Bhadelia, Medical Director, Special Pathogen Unit, Boston University School of Medicine
Dr. Raj Panjabi, Chief Executive Officer, Last Mile Health
Moderator: Bryan Walsh, Contributor, Time Magazine

12:00 PM HOW ADVENTURE CAN SAVE YOUR LIFE

Nothing good happens after 2am, except the most epic experiences of your life.
So says behavioral scientist Jon Levy, author of The 2AM Principle and host of The Influencers Dinners. Levy breaks down the science of adventure. And he would know, having narrowly escaped death while running with bulls in Pamplona and jumping into a moving limousine full of strangers before commandeering their bachelorette party. Adventures don’t happen by accident, and here’s why they’re exactly what your body and mind need.
Jon Levy, Founder, The Influencers; Author, The 2 AM Principle: Discover The Science of Adventure

12:10 PM THE MISSING INGREDIENTS IN HEALTHY EATING

John Mackey, CEO of Whole Foods, is arguably the individual most associated with today’s organic movement and the one most responsible for taking it mainstream. And yet, even as giants like Walmart and Kroger move headlong into the territory that Mackey settled, the very definitions of “healthy food”—and, more important, “healthy eating”—are changing. We talk with the CEO about the new food order—and why consumers are only just beginning to understand what’s good for them.
John Mackey, Co-founder and CEO, Whole Foods Market
Interviewer: Beth Kowitt, Fortune

12:30 PM SWITCH BREAK

12:40 PM LUNCH

1:10 PM CONCURRENT LUNCH SOLUTION SESSIONS

Attendees will choose one of three concurrent lunch sessions.

CONQUERING FORTRESS BRAIN
Personal Wellness Track hosted by Cigna
Manchester Room
One pharmaceutical company after another has failed in its attempt to develop a drug against Alzheimer’s. Likewise, despite decades of tries, there’s still no cure for Parkinson’s disease or even a drug that’s been shown to slow its neurodegenerative progression. Efforts to stop or reverse ALS, Huntington’s, multiple sclerosis and other neurological diseases have similarly been stymied. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding frontiers in the human body—and yet our knowledge of how the brain and mind actually work seems to be growing by leaps each year. How close are we to bridging this divide? How long until what we understand about the brain can help us heal it?
Deborah Brooks, Co-founder and Executive Vice Chairman, The Michael J. Fox Foundation for Parkinson’s Research
Elli Kaplan, Co-founder and CEO, Neurotrack
Dr. David A. Kessler, Professor of Pediatrics and Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco
Bill Maris, Venture Capitalist
Dr. Olivier Oullier, Neuroscientist & Former Head, Global Strategy in Health and Health Care, World Economic Forum
Mary Varghese Presti, Executive Director, Emerging Services, athenahealth
Moderator: Dr. David Agus, USC
Introduction: Dr. Doug Nemecek, Chief Medical Officer, Behavioral Health, Cigna

THE ELUSIVE LIQUID BIOPSY
Intervention Track
Ballroom C1
Every protein fragment, every strand of microRNA, every sentence and mis-sentence of DNA, every immune system marker, every signature of disease in the human being. That all of this could be waiting in, and deciphered from, a tiny sample of blood is a notion that has appealed to medical science since the ancients. And for an equal amount of time, that notion has turned out to be more science fiction—or in one famous case, scandal—instead of breakthrough. Still, the promise of this approach to disease diagnostics is so great that waves of medical entrepreneurs are avidly pursuing the quest.
Dr. Anna D. Barker, Co-director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance; Professor, School of Life Sciences, Arizona State University
Dr. Luis Diaz, Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center.
Helmy Eltoukhy, Co-founder and CEO, Guardant Health
Dr. Sam Hanash, Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center
Dr. Anirban Maitra, Scientific Director, Sheikh Ahmed Center for Pancreatic Cancer Research, MD Anderson Cancer Center
Moderator: Clifton Leaf, Fortune

THE MOBILITY OF CARE—FROM TELEMEDICINE TO FLOATING PHYSICIANS
Value Chain Track
Session hosted by Herman Miller
Capella Room
It seems to be the one inevitability in the digital health revolution—a foundational, digital-fueled shift in how medical care is sought out, delivered and paid for. An explosion of new technologies now connect patients with doctors via smartphone apps—and models are emerging that will let consumers even get house calls from doctors “based” in an Uber, rather than an office. The new platforms will lower cost and conceivably let quality healthcare be available anywhere—so, honestly, what’s standing in our way?
Hill Ferguson, Chief Executive Officer, Doctor On Demand
Len Greer, President, Johnson & Johnson Health and Wellness Solutions
Charles Koontz, Chief Digital Officer, GE Healthcare; President and CEO, GE Healthcare Digital
Dr. Alexi Gharib Nazem, Co-founder and CEO, Nomad Health
Gyre Renwick, Head of Healthcare, Government & Education Partnerships, Lyft
Katherine Ryder, Founder and CEO, Maven
Unity Stoakes, Co-founder and President, StartUp Health
Moderator: Leena Rao, Fortune
Introduction: Paul Iles, Vice President of Finance, Healthcare, Herman Miller, Inc.

SPECIAL LUNCH SESSION: NEXT FRONTIERS OF FERTILITY
Discovery Track
In the high-tech health revolution, there may be no more fertile ground than fertility itself. The worldwide market for fertility services is expected to surpass $21 billion by 2020, and Silicon Valley’s top VCs are taking note—betting that a crop of new companies, apps and technologies will help deliver not only new life into the world, but also billions of dollars. Enter the brave new world of tech-enhanced baby-making.
Angie Lee, Chief Product Officer, Celmatix
Dr. Mary Jane Minkin, Clinical Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University
Jennifer Tye, Vice President and Head, U.S. Operations, Glow
Dr. John Zhang, Founder and Director, New Hope Fertility Center
Moderator: Siobhan O’Connor, TIME

1:50 PM SWITCH BREAK

2:00 PM HOW TO SAVE THE PLANET IN A POST-ANTIBIOTIC WORLD

Last year, the U.S. reported its first-ever death stemming from a superbug resistant to all available antibiotics. The rise of drug-resistant bacteria has compelled the World Health Organization to release a list of 12 pathogens in urgent need of new treatments. But an increasingly vocal chorus of experts says we’re moving far too slowly—and that the age of superbug pandemics may already be upon us. Here’s a simple question: What do we have to do right now to save the world?
Dr. Charles Chiu, Associate Professor, Laboratory Medicine and Director, UCSF-Abbott
Viral Diagnostics and Discovery Center, UC San Francisco
Dr. Jean Patel, Science Lead, ARX Unit, CDC
Dr. Jonathan Thomas, Chair, Governing Board of the California Institute for Regenerative Medicine
Moderator: Bryan Walsh, Time Magazine

2:25 PM DYING HEALTHY

How many of us would truly want to live forever? Or really, is the better aim to live a full life in which we’re healthy nearly until the day we die? Most of us, we suspect, would choose the latter. And yet our entire medical system is designed with the former goal in mind—No, not to have us live forever, but to extend life no matter what the quality of those extra days, weeks, or years might be. But Dr. Sandro Galea, dean of Boston University’s school of public health, offers a heretical question: What if we were to design a healthcare system that actually gave us what we want? How would we spend our dollars then?
Dr. Sandro Galea, Robert A. Knox Professor and Dean, School of Public Health, Boston University

2:35 PM SPECIAL AUGMENTED REALITY VISIT BY DR. TOBY COSGROVE

Dr. Toby Cosgrove, President and CEO, Cleveland Clinic

2:40 PM DISRUPTION BY DESIGN

For all the imaginings of pills of potions, healthcare has long been a device-driven enterprise. And as revolution comes to healthcare in general, it’s storming into med-tech with radical fervor and innovation. What’s in the works for the next generation of implantables, wearables, smart machines, and more?
Michael Mendenhall, Chief Marketing Officer, Chief Corporate Communications Officer, Flex
Interviewer: Leena Rao, Fortune

2:55 PM THE NEXT GENERATION OF DRUGS: A SHOT OF INNOVATION

Groundbreaking new medicines are not the only areas of innovation in biopharma today. Important—and lesser-known advances are happening in the way treatments new and old are being delivered to patients. From implantable devices that provide a steady trickle of medicine over months, to patches that reduce the need for injections, to ingestible sensors that track how people take their meds, the bold new science of drug delivery may be doing as much to improve medicine as the medicines themselves in some cases. The big question: What’s next?
Kurt Graves, Chairman, President and CEO, Intarcia
Behshad Sheldon, President and CEO, Braeburn Pharmaceuticals
Andrew Thompson, Co-Founder and CEO, Proteus Digital Health
Moderator: Dr. David B. Agus, USC

3:20 PM TWO STARTUPS, TEN MINUTES

Katherine Ryder, a former journalist, wants to make sure every woman gets the right information online about prenatal care, postnatal depression, and breastfeeding. So she founded Maven, a company to do just that. Katelyn Gleason, a former actor, figured out an ingenious software application to make medical billing more transparent. She created a hotshot firm called Eligible. Want to change healthcare? M.D. not required.
Katelyn Gleason, Founder and CEO, Eligible
Katherine Ryder, Founder and CEO, Maven
Moderator: Leena Rao, Fortune

3:30 PM DEMO: NEUROTECH—OUT OF THE LAB. INTO OUR LIVES

Your brain is feasting on your senses—and that celebration is telling us plenty about how it works. So what can scientists learn by measuring your brain activity when, say, you listen to a cello solo or view a piece of art? Some key insights, it turns out, about how to take care of patients with a number of disorders. A pioneering—and charismatic—neuroscientist explains why.
Dr. Olivier Oullier, Neuroscientist & Former Head, Global Strategy in Health and Health Care, World Economic Forum
Yao Zhao, Cello Principal, San Diego Symphony
Interviewer: Dr. David B. Agus, USC

3:45 PM BREAK

4:00 PM IS HUBRIS HURTING SCIENCE?

Ambition is the fuel of progress—the stuff that pushes wide-eyed scientists and engineers to pull endless all-nighters in the lab, that motivates inventors and entrepreneurs to bounce back after each defeat. But does having too much of this special sauce lead to self-delusion? At what point does one’s fervent belief in the potential of a new technology or therapy translate into overhype? We sit down with Guardant Health CEO Helmy Eltoukhy to talk about the need for internal reality checks—and ask a question that would be unthinkable in Silicon Valley: Are we rushing our way to failure?
Helmy Eltoukhy, Co-founder and CEO, Guardant Health
Interviewer: Clifton Leaf, Fortune

4:10 PM DEMO: GAME THEORY

Can data help athletes boost their performance as never before? Such is the contention behind the WHOOP Strap, now being worn by Major League Baseball players and other elite athletes. The wearable measures sleep, muscle recovery, and strain—but can that really be the big WHOOP in sports performance? See for yourself.
Will Ahmed, Founder and CEO, WHOOP
Darrell Stuckey, Safety, Los Angeles Chargers, National Football League
Moderator: Erika Fry, Writer, Fortune

4:20 PM HEALTHCARE WITHOUT BUILDINGS

Here’s a quick exercise: Shut your eyes and think of the biggest hospital you know. Imagine it not as a sprawling complex but rather as an eight-story profit-and-loss ledger. Now, it’s no longer a place where people go for surgeries and emergency care; it’s a money pit—a heavy, recurring capital expenditure with costly MRI and CT scanners, brigades of uniformed employees, and floor after floor of patient rooms that need to be forever cleaned and equipped. The only way to make this ledger balance is to fill every bed and keep it filled—and to keep ordering tests on those pricey machines even when they may be unneeded. The problem is, we know that model doesn’t work—and we can’t afford it anymore. But what if we didn’t have to? What if there were hospitals without walls and floors? That radical notion is precisely what some of the most forward-thinking people in healthcare are pondering. An eye-opening conversation.
Yonatan Adiri, Founder and CEO, Healthy.io
Hill Ferguson, Chief Executive Officer, Doctor on Demand
Moderator: Siobhan O’Connor, TIME

4:45 PM TAKING A PRIVATE FIGHT PUBLIC

After his 2014 diagnosis with testicular cancer, Jimmy “Taboo” Gomez, a member of the Black Eyed Peas, waged his own quiet battle for survival. But the six-time Grammy winner says it’s time to get loud. Gomez ignored the signs of cancer for years, he says. Now, he’s pleading with others not to make the same mistake.
Jimmy “Taboo” Gomez, Musician and Member, Black Eyed Peas
Interviewer: Dr. David B. Agus, USC

5:00 PM ADJOURN AND CLOSING RECEPTION